Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07347366
Eligibility Criteria:
Inclusion Criteria:
* Hospitalized patients who require sputum clearance.
* Patients who present with fever or respiratory symptoms (cough, sputum) and, after confirmation of findings on imaging studies, are judged by the clinician to require sputum clearance.
* Adult patients (≥ 18 years) who have signed the informed consent form, or patients for whom consent has been obtained from a legally authorized representative
Exclusion Criteria:
* Patients with severe pneumonia requiring intensive care unit (ICU) treatment.
* Patients with major pulmonary diseases other than pneumonia, such as active tuberculosis or lung cancer.
* Patients with severe respiratory failure (PaO₂/FiO₂ ≤ 200 mmHg).
* Patients with hemodynamically unstable cardiovascular disease (myocardial infarction within the past 3 months, or heart failure of NYHA class 3 or higher).
* Patients hospitalized for head and neck trauma whose surgical site has not yet healed.
* Patients with serious cardiac arrhythmias or hemodynamic instability.
* Patients who have had pneumothorax or massive hemoptysis within the past 6 months, or who currently have hemoptysis.
* Patients who have undergone spinal surgery within the past 6 months or who have acute spinal injury.
* Patients with osteoporosis.
* Patients with bronchopleural fistula.
* Pregnant or breastfeeding women.
* Patients diagnosed with cervical disc disease.
* Individuals who have participated in clinical studies two or more times in the same year, or who have participated in another clinical study within the past 6 months (however, patients enrolled in chronic lung disease cohort studies such as asthma or COPD are allowed).
* Individuals who, in the judgment of the principal investigator or sub-investigator, have clinically significant findings that make them unsuitable for participation in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07347366
Study Brief:
Protocol Section:
NCT07347366